Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-005145

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 22, 2018
Accepted (ET)
Jan 24, 2018 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 22, 2018S5,000$19.55D36,946ISee Footnote
Common StockF4,F5Jan 22, 2018S5,000$19.54D57,405ISee Footnote
Common StockF6,F3Jan 23, 2018S5,000$19.67D31,946ISee Footnote
Common StockF7,F5Jan 23, 2018S5,000$19.68D52,405ISee Footnote
Common StockF8,F3Jan 24, 2018S5,000$19.83D26,946ISee Footnote
Common StockF8,F5Jan 24, 2018S5,000$19.83D47,405ISee Footnote
Common Stockholding———286,975D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses